Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |